Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.38 |
| ▸ | FNTB | P49356 | 3/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.36 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.36 |
| ▸ | PRCP | P42785 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1011519 | 0.78 | RECQL (0.39) | FNTAFNTBRECQLCYP2D6CXCR4 | |
| SCHEMBL31569336 | 0.78 | RECQL (0.39) | FNTAFNTBRECQLCYP2D6CXCR4 | |
| SCHEMBL24317427 | 0.74 | CXCR4 (0.42) | FNTAFNTBRECQLCYP2D6CXCR4 | |
| SCHEMBL24019184 | 0.74 | PRCP (0.58) | FNTAFNTBRECQLCYP2D6CXCR4 | |
| SCHEMBL13783357 | 0.73 | PRCP (0.56) | RECQLPRCP | |
| SCHEMBL19223482 | 0.73 | PRCP (0.56) | RECQLPRCP | |
| SCHEMBL5021308 | 0.71 | OPRL1 (0.35) | FNTAFNTBCYP2D6CXCR4CYP3A4 | |
| SCHEMBL5021310 | 0.71 | OPRL1 (0.35) | FNTAFNTBCYP2D6CXCR4CYP3A4 | |
| SCHEMBL5021309 | 0.71 | OPRL1 (0.35) | FNTAFNTBCYP2D6CXCR4CYP3A4 | |
| SCHEMBL21672474 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217990-A1 | THIENOPYRROLE COMPOUNDS | GILEAD SCIENCES, INC. | 2024-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217990-A1 | THIENOPYRROLE COMPOUNDS | SSB, TPMT, LCP2 | FNTA 2673/4885FNTB 4191/4885RECQL 765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.